Creating anti-infective opportunities

Basilea Capital Markets Day

11 April 2024
Park Hyatt, Zurich

We were pleased to have you at our Capital Markets Day!

You can find the presentation here

Event-Video

Play

Program

We were delighted to have Professor Oliver A. Cornely and Professor Thomas L. Holland as our guest speakers.

13:00	Check-in start
14:00	Welcome David Veitch, CEO
14:15	Financial position & business model Adesh Kaul, CFO incl. Q&A
14:30	The new assets in our drug pipeline: Fosmanogepix, BAL2062 and tonabacase Marc Engelhardt, M.D., Ph.D., CMO
15:00	Coffee-Break
15:30	Treating infectious diseases: progress, current limitations and future needs Invasive fungal infections Professor Oliver A. Cornely, Professor of Translational Research, Faculty of Medicine, University of Cologne Staphylococcus aureus bacteremia Professor Thomas L. Holland, Associate Professor of Medicine, Infectious Diseases, Departement of Medicine, Duke University
16:30	Round table and Q&A
16:50	Key Take Aways & Wrap Up David Veitch, CEO
17:00	Networking & Apéro
18:00	End

If you have further questions or would like to request a meeting with the Management or IR team, please do not hesitate to reach out to Ms. Dung Tran, Investor Relations Coordinator, at NgocDung.Tranbasileacom.